| Waiting time for second kidney transplantation and mortality A Kainz, M Kammer, R Reindl-Schwaighofer, S Strohmaier, V Petr, ... Clinical Journal of the American Society of Nephrology 17 (1), 90-97, 2022 | 18 | 2022 |
| The role of complement in kidney disease V Petr, JM Thurman Nature Reviews Nephrology 19 (12), 771-787, 2023 | 13 | 2023 |
| Association Between SARS-CoV-2 Messenger RNA Vaccines and Lower Infection Rates in Kidney Transplant Recipients: A Registry-Based Report I Zahradka, V Petr, I Modos, M Magicova, L Dusek, O Viklicky Annals of Internal Medicine 175 (7), 961-968, 2022 | 8 | 2022 |
| Rejection-associated phenotype of de novo thrombotic microangiopathy represents a risk for premature graft loss V Petr, P Hruba, M Kollar, K Krejci, R Safranek, S Stepankova, ... Transplantation Direct 7 (11), e779, 2021 | 8 | 2021 |
| An interleukin 6‐based genetic risk score strengthened with interleukin 10 polymorphisms associated with long‐term kidney allograft outcomes SK Eskandari, M Gaya da Costa, B Faria, V Petr, JR Azzi, SP Berger, ... American Journal of Transplantation 22, 45-57, 2022 | 6 | 2022 |
| Local Angiotensin-Converting Enzyme 2 Gene Expression in Kidney Allografts Is Not Affected by Renin-Angiotensin-Aldosterone Inhibitors M Cahova, M Kveton, V Petr, D Funda, H Dankova, O Viklicky, P Hruba Kidney and Blood Pressure Research 46 (2), 245-249, 2021 | 5 | 2021 |
| MCPggaac haplotype is associated with poor graft survival in kidney transplant recipients with de novo thrombotic microangiopathy V Petr, D Csuka, P Hruba, Á Szilágyi, M Kollar, A Slavcev, Z Prohaszka, ... Frontiers in Immunology 13, 985766, 2022 | 3 | 2022 |
| Early referring saved lives in kidney transplant recipients with COVID-19: a beneficial role of telemedicine I Zahradka, V Petr, K Jakubov, I Modos, F Hruby, O Viklicky Frontiers in Medicine 10, 2023 | 2 | 2023 |
| First Booster of SARS-COV-2 mRNA Vaccine Is Not Associated With Alloimmunization and Subclinical Injury of Kidney Allograft V Petr, I Zahradka, I Modos, M Roder, A Prewett, M Fialova, J Machkova, ... Transplantation 107 (2), e62-e64, 2023 | 1 | 2023 |
| SARS-CoV-2 mRNA Vaccination Is Not Associated With the Risk of Allosensitization in Patients Awaiting Kidney Transplantation I Zahradka, V Petr, I Modos, K Kabrtova, A Slavcev, O Viklicky Transplantation 106 (12), e522-e524, 2022 | 1 | 2022 |
| Background risk should be taken into account when reporting vaccine effectiveness I Zahradka, V Petr, M Magicova, O Viklicky American Journal of Transplantation 22 (7), 1927-1928, 2022 | 1 | 2022 |
| MP175ATYPICAL HEMOLYTIC UREMIC SYNDROME-VERY EARLY TREATMENT IS A WAY TO SUCCESS? V Petr, I Zahradka, K Kratka, M Grussmannova, E Honsova, I Rychlik NEPHROLOGY DIALYSIS TRANSPLANTATION 32 (3), iii492-iii492, 2017 | 1 | 2017 |
| Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine Booster Doses in Kidney Transplant Recipients: Results of a 12-mo Follow-up From a Prospective Observational Study V Petr, I Zahradka, I Modos, M Roder, M Fialova, J Machkova, K Kabrtova, ... Transplantation Direct 10 (6), e1645, 2024 | | 2024 |
| Calcineurin inhibitor toxicity in de novo thrombotic microangiopathy—Is the culprit what we think it is? V Petr, I Zahradka, O Viklicky American Journal of Transplantation, 2024 | | 2024 |
| Morning Administration Enhances Humoral Response to SARS-CoV-2 Vaccination in Kidney Transplant Recipients I Zahradka, F Tichanek, M Magicova, I Modos, O Viklicky, V Petr American Journal of Transplantation, 2024 | | 2024 |
| Molecular Imaging of Kidney C3d Deposits to Monitor Lupus Nephritis: TH-PO556 F Poppelaars, B Renner, CA Foss, J Laskowski, V Petr, L Kulik, ... Journal of the American Society of Nephrology 34 (11S), 245, 2023 | | 2023 |
| 198 Novel natural antibodies targeted against cardiolipin are associated with higher risk of rejection in kidney transplant recipients V Petr, F Poppelaars, J Laskowski, B Renner, P Heeger, J Thurman Immunobiology 228 (5), 152648, 2023 | | 2023 |
| When Is a Second Kidney Transplant Lifesaving? Effect of Waiting Time on Mortality in a Retrospective Cohort Study Using Target Trial Emulation: PO2101 A Kainz, M Kammer, R Reindl-Schwaighofer, S Strohmaier, V Petr, ... Journal of the American Society of Nephrology 32 (10S), 643, 2021 | | 2021 |
| Nefrokalcinóza po transplantaci ledviny jako vzácný projev karcinomu příštítných tělísek I Zahrádka, V Petr, T Roháľ, J Malušková, C Povýšil, O Viklický | | |
Prof. Ondrej ViklickyInstitute for Clinical and Experimental Medicine在 ikem.cz 的电子邮件经过验证
